SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-000319
Filing Date
2024-01-17
Accepted
2024-01-17 10:46:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4686
  Complete submission text file 0001959173-24-000319.txt   6103
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38276 | Film No.: 24537110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address APELLIS PHARMACEUTICALS, INC. 100 5TH AVENUE, 3RD FLOOR WALTHAM MA 02451
Business Address
Eisele Jeffrey (Reporting) CIK: 0001827326 (see all company filings)

Type: 144